Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1270 (7 June), doi:10.1136/bmj.39598.708333.DB
Ray Moynihan, Melbourne
The first 150 words of the full text of this article appear below. |
An internationally respected drug advisory body based at the University of British Columbia is facing closure after a report to the provincial minister for health called for its "replacement."
The Therapeutics Initiative (www.ti.ubc.ca) produces evidence based reviews of drugs for doctors, policy makers, and the public, and the group has strict conflict of interest policies, which guarantee that its findings are as free of industry influence as possible.
A report from a task force of nine, submitted to the health minister of British Columbia last month, claims that although the Therapeutics Initiative "has served an important role in the past, it is now widely regarded as being in need of either substantial revitalisation or replacement. The task force regards replacement as the better option."
The health minister, George Abbott, said that he would accept the task forces recommendations, sparking a strong global reaction in support of the independent
CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+